Medical Uses and Adverse Effects of Psilocybindoi:10.4088/PCC.23f03652Ghaznavi, SharminBernardez, Lourdes M.Stern, Theodore A.Primary Care Companion for CNS Disorders (2155-7772)
A 25-mg dose of psilocybin reduced depression scores significantly more than a 1-mg dose over a 3-week period. However, it was associated with adverse effects, according to the results of a phase 2 trial (NCT03775200) of individuals with treatment-resistant depression. Investigator...
Psychedelic (5-HT2Areceptor agonists, such as psilocybin) and 3,4-methylenedioxymethamphetamine (MDMA)–based therapies have shown promise in recent clinical studies in the treatment of mental health conditions, including alcohol use disorder, major depressive disorder, and posttraumatic stress disorder.1...
And exposure to lead has been linked to a range ofadversehealth effects, say experts. — Ali Francis,Bon Appétit, 1 Feb. 2024 Sebastien is not a threat to land and won’t bring anyadverseaffect to any nearby areas over the next few days. ...
Mushrooms such as Psilocybe and Stropharia contain the hallucinogenic alkaloid psilocybin. Claviceps purpurea contains ergotoxic alkaloids and lysergic acid. Arthrinium sp often contaminates cereals and sugar cane and causes a neurotoxic syndrome mediated by mycotoxins....
DRUG side effectsPSYCHOLOGICAL distressMEDICAL personnelPSILOCYBINDRUG prescribingDULOXETINEDRUG utilizationContext: Cancer is a complex neoplastic disorder. Globally, it is said to be the second leading cause of death. Aim: The aim of the present study was to assess the ...
This chapter briefly highlights the neurological and related adverse events associated with pharmacokinetics-based interactions between clinical drugs and commonly used illicit substances of herbal or fungal origin, such as ayahuasca, cannabis (marijuana), cocaine, psilocybin, khat, salvia, kratom, and ...